StemCells Inc. Names Maria Millan, M.D., F.A.C.S., To Lead Its Liver Cell Transplant Program

PALO ALTO, Calif.--(BUSINESS WIRE)--Jan. 10, 2006--StemCells, Inc. (NASDAQ: STEM) today announced that Dr. Maria Millan has joined the Company as Director, Liver Cell Transplant Program. Dr. Millan, a transplant surgeon, is on leave from her positions as Associate Professor of Surgery, Division of Multi-Organ Transplant, and Director of Pediatric Transplant Programs, Kidney & Liver, at Stanford University School of Medicine. Dr. Millan has a long-standing interest in the potential of cellular transplants and has been closely involved with the Company’s liver stem cell program as a member of StemCells, Inc.'s Scientific Advisory Board. She joins StemCells, Inc. now to lead the Company’s efforts to bring its candidate liver stem cell into the clinic.

MORE ON THIS TOPIC